Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives

Surgical resection followed by adjuvant cisplatin-based chemotherapy is the recommended treatment for patients with completely resected stage IB–IIIA non-small cell lung cancer (NSCLC). Even with the best management, recurrence is common and increases with disease stage (stage I: 26–45%; stage II: 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Kris, Mark G., Mitsudomi, Tetsuya, Peters, Solange
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183392/
https://www.ncbi.nlm.nih.gov/pubmed/37197636
http://dx.doi.org/10.21037/tlcr-22-723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183392/
https://www.ncbi.nlm.nih.gov/pubmed/37197636
http://dx.doi.org/10.21037/tlcr-22-723

Ejemplares similares